LUZ and Pfizer to Jointly Speak at 15th Annual eDM
Summary
“The dossier content project is a great example of how successful collaboration between our professional translation teams and our client at Pfizer led to millions of dollars in savings annually,” said Rivas.Through its enterprise-level AURORA technology platform and regional offices, LUZ delivers peace of mind to corporate life science clients across the globe.San Francisco, CA, November 19, 2014 --( PR.com )-- LUZ, Inc., a global provider of life science translation services, today announced that Monique Rivas, cofounder and chairman of LUZ and Katy Juliet Page, M.B.A., senior director submissions and operations support at Pfizer Ltd., United Kingdom will copresent at the DIA 15th Annual Conference on Electronic Document Management (eDM) in Berlin.“I’m looking forward to sharing our strategy for global standardization and explaining the benefits of using our AURORA technology at the DIA eDM conference in December.”Who: Monique Rivas of LUZ and Katy Juliet Page, M.B.A. of PfizerWhat: “Business Models to Get the Regulatory Work Done” session, “Harmonization and Standardization of Dossier Content, Information and Processes” presentation.Where: Drug Information Association (DIA) 15th Annual Conference on Electronic Document Management (eDM) at the Maritim Hotel Berlin.When: Wednesday, Dec. 03, 2014 from 8:30-10:00 a.m.To find out more, or to inquire about meeting LUZ at the event, please contact us at http://www.luz.com/contact-us.The Drug Information Association provides educational opportunities and facilitates communication among pharmaceutical and medical product development professionals.About LUZ, Inc.LUZ, Inc. was founded in 1994 on a straightforward business philosophy to provide high-quality translation services and solutions to life science companies worldwide.Through its enterprise-level AURORA technology platform and regional offices, LUZ delivers peace of mind to corporate life science clients across the globe.